# FDA Inspection 1099631 - Liuzhou Liangmianzhen (LMZ) Co., Ltd. - July 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/liuzhou-liangmianzhen-lmz-co-ltd/36d09f59-399f-4b1f-af03-14ceb7e9d040
Source feed: FDA_Inspections

> FDA Inspection 1099631 for Liuzhou Liangmianzhen (LMZ) Co., Ltd. on July 05, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099631
- Company Name: Liuzhou Liangmianzhen (LMZ) Co., Ltd.
- Inspection Date: 2019-07-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1236678 - 2024-03-22](https://www.keypedia.com/records/fda_inspections/liuzhou-liangmianzhen-lmz-co-ltd/f6ae9aa2-064f-4bda-9691-16e3f505a520)

Company: https://www.keypedia.com/companies/liuzhou-liangmianzhen-lmz-co-ltd/65235d99-a657-42fc-a43b-469f3c722a68

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c